The Trend Toward a Paperless Hospital
In the second of our series on the Harvard Business Review’s Ten Innovations That Will Transform Medicine, we take a look at evidence-based decision-making.
Uncategorized
FDA to Collaborate with Pharma Companies on New TB Initiative
A number of pharmaceutical companies will collaborate with FDA scientists to test new TB combination therapies and identify promising candidates.
IntelliSoft Group Part of Trend Toward Healthcare Accountability
The Harvard Business Review recently published a list of 10 innovations poised to change the medical industry in 2010.
Translating Data Into Better Healthcare
Strategic Medicine (SMI) specializes in patient and disease stratification with the end goals of providing better healthcare and identifying unmet clinical needs.
SEA Medical: Technology to Prevent Deadly IV Mistakes
Intravenous (IV) drugs leave a huge margin for human error, particularly at the point of administration.
Pressure BioSciences Aims for Improved Sample Preparation
Pressure BioSciences seeks to improve sample yield with its novel technology platform, known as pressure cycling technology (PCT).
Chembio Diagnostics Tackles Infectious Diseases with Rapid-Diagnostic Platform
Chembio Diagnostics specializes in the development of advanced diagnostic tests for infectious diseases such as HIV and syphilis.
[OneMedForum] Senesco Technologies: Life and Death on a Cellular Level
“Programmed cell death” sounds a bit sinister, but it’s actually a normal and healthy process.
[OneMedForum] Micrus Endovascular: Help for Stroke Patients
Micrus Endovascular is the only publicly traded company focused on strokes.
Diabetes Drug Wins Approval, Helps the Competition
The approval of Novo Nordisk’s diabetes drug Victoza has led to an unintended benefit for a competitor.